Sentences with phrase «most chemotherapy»

Most chemotherapy is well - tolerated by dogs and cats.

Most chemotherapy drugs can not differentiate between fast - growing cancer cells and other normal cells in our body that grow quickly.

Perhaps the most significant observation documented in this study was the ability of lauric acid to target cancer cells but not affect healthy cells, unlike most chemotherapy drugs.

The findings suggest that in this setting, most chemotherapy is given appropriately to non — critically ill patients,» wrote Anita J. Kumar, of Tufts Medical Center, and colleagues.

While most chemotherapy drugs kill all rapidly dividing cells in the body, causing serious side effects which limit their use, a drug that inhibits telomerase would only affect those cells that are immortal and malignant.

There aren't a lot effective treatments for this aggressive disease — it's resistant to most chemotherapy — and so the need for new approaches is great.

Why is it that pancreatic cancer seems to be maddeningly resistant to most chemotherapy regimens?

Most Chemotherapy Drugs for Cancer: Since they kill cells in the mother's body, they may harm the baby as well.

Cyclophosphamide, Doxorubicin, and most chemotherapy drugs for cancer — these drugs kill cells in the mother's body and may harm the baby.

«Most chemotherapies kill cancer cells through apoptosis, and the cancer cells that escape apoptosis are the root cause of chemotherapy resistance and tumor progression,» said Chi.

Immunosuppression is a common side - effect of most chemotherapies used in cancer treatment.

Not exact matches

The bottom line is that Gates gives this book his most enthusiastic endorsement, concluding: «I don't know how Kalanithi found the physical strength to write this book while he was so debilitated by the disease and then potent chemotherapy.

«I hope that someday all of you on the advisory committee can tell your families for generations that you were part of the process that ended the use of toxic treatments like chemotherapy and radiation as standard treatment, and turned blood cancers into a treatable disease that even after relapse most people survive.»

Chemotherapy works by killing cancer cells by targeting fast - dividing cells, and in most cases, kills off some healthy cells along the way, including nerve cells in the brain.

Unlike chemotherapy, which involves administering powerful drugs that kill both cancerous and healthy cells (most healthy cells can repair themselves), immunotherapies harness the power of the immune system to help it identify and knock out just the cancerous cells.

Blankfein, who underwent chemotherapy for cancer more than two years ago, led the firm through the financial crisis in better shape than most rivals, and the company capitalized with record trading revenues.

April 16 Merck & Co's immunotherapy Keytruda plus chemotherapy significantly improved overall survival versus chemotherapy alone in newly - diagnosed patients with advanced non-small cell lung cancer in a highly - anticipated study that appears to cement the company's lead in the most lucrative oncology market.

For instance, most common adult solid tumors that are not cured by surgical removal are resistant to chemotherapy or radiation control, yet drug therapy is frequently offered as a «possibly effective» treatment because both patient and physician want to believe it so.

Being one of the most thoroughly researched plants ever; it's been claimed to match the effectiveness of drugs including statins like liptor, corticosteroids, antidepressants, anti-inflammatories, and drugs for chemotherapy and diabetes.

It's worth nothing, however, that they substances are often most effective when used to complement chemotherapy and other medical interventions.

In what often must seem like a wicked twist of fate, most patients who receive radiation or chemotherapy to the head and neck develop serious oral lesions.

Most medications are safe in breastfeeding, with rare exceptions such as cytotoxic chemotherapy drugs.

Currently, most breast cancer patients are treated not only with surgery, but also radiation, hormone therapy or chemotherapy.

Most of the time, he said, Watson affirms that the decisions he had already come to were correct, such as one breast cancer patient who needed aggressive chemotherapy.

Paclitaxel and another chemotherapy drug, carboplatin, are considered standard, first - line treatments for advanced ovarian cancer, experts say, and most patients respond to the drugs initially.

In a recent study, working with a team of researchers, Danino demonstrated that bacteria in pancreatic tumors degrade a chemotherapy drug — Gemcitabine — most commonly used to treat patients who have pancreatic cancer.

The experimental drug nintedanib, combined with standard chemotherapy with paclitaxel, causes a total remission of tumours in 50 % of patients suffering from early HER - 2 - negative breast cancer, the most common type of breast cancer.

The declaration states that without action, «there will be fewer options for the protection of people most vulnerable to serious life - threatening infections, especially women giving birth, newborns, patients with certain chronic diseases or those undergoing chemotherapy or surgery.»

Patients with metastatic non-small cell lung cancer will always progress after chemotherapy, so most patients go on to be treated with immunotherapy, a type of therapy that uses the body's immune system to fight cancer.

For decades most cancers have been treated with a core standard of treatments that include surgery, radiation, and chemotherapy.

By hitting breast cancer cells with a targeted therapeutic immediately after chemotherapy, researchers from Brigham and Women's Hospital (BWH) were able to target cancer cells during a transitional stage when they were most vulnerable, killing cells and shrinking tumors in the lab and in pre-clinical models.

By hitting breast cancer cells with a targeted therapeutic immediately after chemotherapy, researchers were able to target cancer cells during a transitional stage when they were most vulnerable.

In a continuation of this work, Goldman is also using mathematical modeling to pursue the most effective dose of chemotherapy to induce the vulnerable transition state of the cancer cell demonstrated in this research.

Once the disease spreads to other parts of the body, most patients are not candidates for surgery and receive chemotherapy as their primary treatment.

Treatments aimed at revving up the immune system's attack on the cancer may be the most promising approach to cancer therapy since combination chemotherapy.

With multiple myeloma, most patients live four to seven years from their date of diagnosis, and most become resistant to chemotherapy drugs over time.

Chemotherapy and radiotherapy alone are relatively unsuccessful in treating the disease, and while surgery to remove the tumour offers the best chance of survival, most patients are diagnosed when the cancer has already spread to other organs.

Most cancer chemotherapy relies on cells absorbing drugs by diffusion across the cell membrane.

«CRKII most likely regulates the stability of mutated epidermal growth factor receptors and drives cancer growth by promoting signaling, or communication, within cancer cells,» said Julia Petschnigg, lead author on the paper and a postdoctoral fellow at U of T. «We found that a combinatorial chemotherapy that inhibits those mutated receptors and CRKII could be beneficial in treating lung cancer.»

«NIR light may identify breast cancer patients who will benefit most from chemotherapy.»

Though chemotherapy might kill most of the cancer, tiny populations of drug - resistant cancer cells manage to survive and propagate.

One of the most significant impairments of the quality of life after a chemotherapy is infertility.

Most importantly, the doxorubicin - decorated diamonds had no effect on white blood cell count, an indicator of immune system activation that's often the deciding factor in whether a patient can continue chemotherapy.

The initial experiments made use of cancer cells that Quiñones - Hinojosa and his team removed from willing patients and grew in the laboratory until they formed little spheres of cells, termed oncospheres, likely to be the most resistant to chemotherapy and radiation, and capable of creating new tumors.

The people who would benefit most from better antifungal agents are those with AIDS, those receiving chemotherapy and those who have undergone transplant surgery.

The research team evaluated the combination of the biologic therapy brentuximab vedotin (Adcetris), a monoclonal antibody - drug conjugate, with the chemotherapy drug gemcitabine (Gemzar) in 42 pediatric and young - adult patients with Hodgkin lymphoma, the most common cancer in young people ages 15 to 29.

«We hope that our test will significantly improve the odds of survival of breast cancer patients by allowing doctors to identify the most effective but least toxic form of chemotherapy for each individual patient before the treatment begins.»

«These are the cells that can break away from a tumor and metastasize; these are the cells you most want to kill with chemotherapy.

Prior studies that examined the impact of cancer treatment decisions on employment showed that patients who received chemotherapy were most likely to experience longer disruptions in or loss of employment, but changes in breast cancer management in recent years have shifted recommendations away from chemotherapy for early stage breast cancer.

They find that the cells can remain dormant during chemotherapy that kills off most of the cancer and can give rise to new tumors once the drug treatment stops.